DE69835368D1 - Verwendung von tgf beta oder activin zur behandlung und diagnose von unfruchtbarkeit - Google Patents

Verwendung von tgf beta oder activin zur behandlung und diagnose von unfruchtbarkeit

Info

Publication number
DE69835368D1
DE69835368D1 DE69835368T DE69835368T DE69835368D1 DE 69835368 D1 DE69835368 D1 DE 69835368D1 DE 69835368 T DE69835368 T DE 69835368T DE 69835368 T DE69835368 T DE 69835368T DE 69835368 D1 DE69835368 D1 DE 69835368D1
Authority
DE
Germany
Prior art keywords
barreness
activin
diagnosis
treatment
tgf beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69835368T
Other languages
English (en)
Other versions
DE69835368T2 (de
Inventor
Anne Robertson
Paul Tremellen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Adelaide
Original Assignee
University of Adelaide
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Adelaide filed Critical University of Adelaide
Publication of DE69835368D1 publication Critical patent/DE69835368D1/de
Application granted granted Critical
Publication of DE69835368T2 publication Critical patent/DE69835368T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/495—Transforming growth factor [TGF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Mycology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69835368T 1997-03-06 1998-03-06 Verwendung von tgf beta oder activin zur behandlung und diagnose von unfruchtbarkeit Expired - Fee Related DE69835368T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO550897 1997-03-06
AUPO5508A AUPO550897A0 (en) 1997-03-06 1997-03-06 Treatment and diagnosis of an infertility condition
PCT/AU1998/000149 WO1998039021A1 (en) 1997-03-06 1998-03-06 TREATMENT AND DIAGNOSIS OF INFERTILITY USING TGFβ OR ACTIVIN

Publications (2)

Publication Number Publication Date
DE69835368D1 true DE69835368D1 (de) 2006-09-07
DE69835368T2 DE69835368T2 (de) 2007-08-23

Family

ID=3799811

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69835368T Expired - Fee Related DE69835368T2 (de) 1997-03-06 1998-03-06 Verwendung von tgf beta oder activin zur behandlung und diagnose von unfruchtbarkeit

Country Status (9)

Country Link
US (2) US7204978B1 (de)
EP (2) EP1743649A1 (de)
AT (1) ATE333890T1 (de)
AU (1) AUPO550897A0 (de)
CA (1) CA2283270A1 (de)
DE (1) DE69835368T2 (de)
DK (1) DK1028743T3 (de)
ES (1) ES2268765T3 (de)
WO (1) WO1998039021A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8106001B2 (en) * 1996-08-27 2012-01-31 University Of South Florida Diagnostic markers of human female infertility
AU2002951531A0 (en) * 2002-09-20 2002-10-03 The University Of Adelaide Treatment and diagnosis of an infertility condition by measuring or inhibiting interferon-y
WO2007113682A2 (en) * 2006-04-06 2007-10-11 Novozymes Gropep Ltd Tgf-beta pharmaceutical compositions
WO2007130619A1 (en) * 2006-05-03 2007-11-15 The Trustees Of The University Of Pennsylvania Compositions and methods for regulating osteoclast differentiation, activation and bone resorption
EP2090588A4 (de) 2006-10-23 2010-04-07 Neocodex S L In-vitro-verfahren zur prognose und/oder diagnose von überempfindlichkeit gegen estrogene oder substanzen mit estrogener wirkung
WO2008070902A1 (en) * 2006-12-11 2008-06-19 Novozymes Biopharma Au Limited Tgf-beta compositions for treating infertility
DE102007045935B4 (de) * 2007-09-25 2015-02-12 Philipps-Universität Marburg Fertilitätstest
GB201314452D0 (en) 2013-08-13 2013-09-25 Ostara Biomedical Ltd Embryo implantation
GB201501302D0 (en) 2015-01-27 2015-03-11 Ostara Biomedical Ltd Embryo implantation
GB201517523D0 (en) 2015-10-05 2015-11-18 Ostara Biomedical Ltd Methods and compositions for managing reproduction
CN115868447B (zh) * 2023-02-15 2024-06-18 新疆天澳牧业有限公司 一种青年牛同期返情加定时输精的繁殖管理方法
CN116987201B (zh) * 2023-09-27 2023-12-08 贝格探索(成都)科技有限公司 调控哺乳动物生殖能力的多聚重组蛋白、制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2065673T3 (es) 1990-01-08 1995-02-16 Genentech Inc Procedimiento para aumentar la fertilidad en las hembras.
US5166190A (en) * 1990-01-08 1992-11-24 Genentech, Inc. Method for increasing fertility in males
US5395825A (en) * 1993-03-10 1995-03-07 Yale University Fertility regulation with transforming growth factor β
GB9316369D0 (en) * 1993-08-06 1993-09-22 Surface Active Ltd Diagnostic method

Also Published As

Publication number Publication date
CA2283270A1 (en) 1998-09-11
ES2268765T3 (es) 2007-03-16
EP1028743B1 (de) 2006-07-26
EP1743649A1 (de) 2007-01-17
DE69835368T2 (de) 2007-08-23
US7204978B1 (en) 2007-04-17
EP1028743A4 (de) 2002-06-12
WO1998039021A1 (en) 1998-09-11
ATE333890T1 (de) 2006-08-15
DK1028743T3 (da) 2006-11-27
AUPO550897A0 (en) 1997-03-27
US20060177459A1 (en) 2006-08-10
EP1028743A1 (de) 2000-08-23

Similar Documents

Publication Publication Date Title
DE69835368D1 (de) Verwendung von tgf beta oder activin zur behandlung und diagnose von unfruchtbarkeit
DE3686361T3 (de) Verwendung von Bismuth zur Herstellung von Medikamenten zur Behandlung von Magen-Darmstörungen, die von Campylobacter polyridis verursacht sind.
DE3887353T2 (de) Behandlungsverfahren für magen-darm-krankheiten.
ATE255902T1 (de) Ein anti-idiotypischer antikörper und seine verwendung in der diagnose und therapie von hiv- verwandten krankheiten
AT385826B (de) Reibring fuer kupplungen oder bremsen, verfahren und vorrichtung zum herstellen des reibringes
ATE8844T1 (de) Vorrichtung zur phototherapeutischen behandlung der hyperbilirubinaemie.
IT1247157B (it) Canali di guida biodegradabili e bioassorbibili da impiegare per la rigenerazione nervosa.
ATE1443T1 (de) Mittel zur behandlung allergischer reaktionen.
HUT47427A (en) Bezafibrat for treating diabetes
DE3856329D1 (de) Verwendung von Ethisterone zur topischen Behandlung von Akne oder androgenetischer Alopezie
SE8800321D0 (sv) Metallurgisk styrmetod
ES538403A0 (es) Procedimiento para la obtencion de antipodas opticos del (+7-1,7-difenil-3-metilaza-7-ciano-8-metil-nonano
PT82752A (en) Process for preparing polycyclic quinoline naphthyridine and pyrazinopyridine derivatives
ATE56363T1 (de) Verfahren zur herstellung von keimabgetoeteten oder in ihrer virulenz abgeschwaechten substanzen sowie deren verwendung.
DE69129623T2 (de) Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozide
ATE6256T1 (de) N-(4-phenyl-2-thiazolyl)-oxamidsaeure-2ethoxyethylester, verfahren zu seiner herstellung und diesen enthaltende therapeutische mittel.
PT84658B (pt) Processo para a preparacao de derivados de naftiridina e piridopirazina substituidas com arilo
DE69021584T2 (de) Behandlung von abgas.
DE3885713T2 (de) Synchrotronstrahlungsquelle und Methode für ihre Herstellung.
DE58901297D1 (de) Noremopamil, seine herstellung und verwendung.
DE3887137D1 (de) Mittel zur prophylaxe und behandlung einer pankreatischen erkrannkung oder dergleichen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee